ArticleBlood cancer journal2022

Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis.

Daehun Kwag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.